Prescription of Chinese herbal compound decoction containing honeysuckle flower and forsythia, radix bupleuri and cassia twig for treating influenza and preparation method

Abstract

The invention relates to a prescription of a traditional Chinese medicine compound soup of lonicera and forsythia and cinnamomum wilsonii gamble for treating flu and a method for preparing the same. Effective compositions of the prescription consist of the following raw material medicines in percentage by weight: 3 to 75 portions of honeysuckle, 3 to 75 portions of fructus forsythiae, 2 to 50 portions of radix bupleuri, 4 to 100 portions of rhizoma paridis, 2 to 50 portions of balloonflower root, 2 to 50 portions of radices paeoniae alba, 3 to 75 portions of figwort, 2 to 50 portions of ephedra, 2 to 50 portions of cassia twig, 2 to 50 portions of baikal skullcap root, and 1 to 30 portions of liquorice; the effective composition contains no any western medicine composition and in particular contains no antibiotics so as to avoid side effect brought by western medicine. Medicinal preparations comprise troche, granule, capsule, drop pill, oral liquid, and injection. Compared with the western medicine for treating the flu, the prescription of the traditional Chinese medicine compound soup of the lonixera and forsythia and the cinnamomum wilsonii gamble has obvious treatment efficacies on rapidly controlling symptom and shortening treatment time, has functions of resisting virus and inflammation, defervescing and easing pain in clinical pharmacology, and has high safety, no toxicity, and no side effect.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine preparations, and in particular relates to a compound traditional Chinese medicine preparation for treating influenza and a preparation method thereof. Background technique [0002] The question of influenza has long plagued the medical world. Due to the variation of influenza strains, the prevention of influenza is not effective, and the epidemic of influenza poses a serious threat to society. The emergence of more complications has caused various adverse consequences and a great consumption of health resources. At present, Western medicine still has a relatively large research space for the effective treatment of influenza. The current chemically synthesized antiviral drugs for the treatment of influenza lack definite clinical efficacy reports, and have obvious toxic and side effects. There is no better way to prevent influenza than vaccination. However, influenza vaccine ...

AI Technical Summary

Problems solved by technology

However, influenza vaccine immunotherapy also has shortcomings. Due to the strong variability of influenza virus, the effect of influenza vaccine depends on whether the type of vaccine strain matches the type of epidemic strain. If it does not match, it will be completely invalid. The research cycle of influenza vaccine is long Timely tracking of mutated flu strains is difficult and costly

Images